Isa 2024 Amyloidosis. The journal of protein folding disorders;. Astrazeneca and its rare disease division, alexion, are set to present a comprehensive array of 14 studies on amyloidosis therapies at the upcoming.
Comprehensive data and breakthroughs related to amyloidosis, brought to you in collaboration with the cardionerds, from the international society of amyloidosis. Treatment, management and future directions.